Huron Consulting Group (NASDAQ:HURN) Announces Earnings Results

Huron Consulting Group (NASDAQ:HURN - Get Free Report) released its quarterly earnings data on Tuesday. The business services provider reported $1.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.52 by $0.38, Zacks reports. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The company had revenue of $399.31 million during the quarter, compared to the consensus estimate of $380.62 million. Huron Consulting Group updated its FY 2025 guidance to 6.800-7.600 EPS.

Huron Consulting Group Stock Up 1.9 %

HURN traded up $2.88 on Friday, reaching $152.46. The company's stock had a trading volume of 243,800 shares, compared to its average volume of 133,049. The stock has a market cap of $2.70 billion, a price-to-earnings ratio of 33.14 and a beta of 0.59. Huron Consulting Group has a 1 year low of $84.26 and a 1 year high of $153.77. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.61 and a quick ratio of 1.61. The business's 50 day moving average is $127.53 and its 200 day moving average is $118.15.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Truist Financial reiterated a "buy" rating and issued a $165.00 price target (up from $140.00) on shares of Huron Consulting Group in a report on Wednesday. William Blair reiterated an "outperform" rating on shares of Huron Consulting Group in a report on Wednesday. Barrington Research upped their price target on Huron Consulting Group from $142.00 to $167.00 and gave the stock an "outperform" rating in a report on Thursday. Benchmark lifted their price objective on shares of Huron Consulting Group from $140.00 to $165.00 and gave the company a "buy" rating in a research note on Wednesday. Finally, Wedbush assumed coverage on shares of Huron Consulting Group in a research note on Monday, February 3rd. They issued an "outperform" rating for the company. Six research analysts have rated the stock with a buy rating, According to MarketBeat.com, Huron Consulting Group currently has an average rating of "Buy" and an average target price of $151.75.

Insider Activity

In other news, Director H Eugene Lockhart sold 12,500 shares of the stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $150.00, for a total transaction of $1,875,000.00. Following the transaction, the director now owns 12,172 shares of the company's stock, valued at approximately $1,825,800. This trade represents a 50.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director James H. Roth sold 2,000 shares of the stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $123.70, for a total transaction of $247,400.00. Following the transaction, the director now directly owns 52,825 shares in the company, valued at $6,534,452.50. The trade was a 3.65 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 21,084 shares of company stock worth $2,942,539. 2.02% of the stock is currently owned by insiders.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.